Janel Life Sciences

Janel Life Sciences is the life sciences operating business of Janel focused on research-use and diagnostic-related reagents rather than therapeutic drug development. The business manufactures and distributes monoclonal and polyclonal antibodies, diagnostic reagents, and other immunoreagents for biomedical research, and also provides custom antibody manufacturing and OEM production services. Public disclosures describe it as part of Janel Corporation’s Life Sciences segment, with brands including Antibodies Incorporated and, historically, companies in a broader Janel Life Sciences group such as Aves Labs, PhosphoSolutions, and ImmunoChemistry Technologies. In April 2026, Janel Life Sciences LLC expanded through the acquisition of BioPorto’s antibody business, including research-use-only antibodies, clones, inventory, and related contracts. Overall, it appears to be a commercial life science tools and services business serving academic, nonprofit, diagnostic, biotech, and pharma customers.